
    
      -  collection of epidemiological data for APL: age distribution, prognostic factors,
           distribution of subgroups, incidence

        -  documentation of efficacy and safety of the first line and salvage therapy in APL
           including

        -  documentation of minimal residual disease (MRD)

        -  correlation of clinical outcomes with chosen therapy

        -  collection and evaluation of quality of life

        -  validation of published prognostic factors / new potential prognostic factors

        -  acquisition of bone marrow, peripheral blood and buccal swab samples for biobanking and
           translational studies under the umbrella of the specific study-group biobanking concepts
    
  